Skip to main content
Rapid molecular testing for TB to guide respiratory isolation in the U.S.: A cost-benefit analysis
Published Web Location
http://europepmc.org/articles/PMC3835836?pdf=renderNo data is associated with this publication.
Abstract
Background: Respiratory isolation of inpatients during evaluation for TB is a slow and costly process in low-burden settings. Xpert MTB/RIF (Xpert) is a novel molecular test for tuberculosis (TB) that is faster and more sensitive but substantially more exp
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.